Physician Assistant, Medical · Boise, ID
NPI
1073915963
Since 2014
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1499 W Hays St
Boise, ID, 83702
Phone (208) 275-8585
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$6.4M
7,182 prescriptions
Company payments, 2025
$12K
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jessica Bishop prescribed most often to Medicare patients was Xcopri (Cenobamate), with 858 prescriptions and refills. In total Jessica Bishop wrote 7,182 Medicare prescriptions that cost $6.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Xcopri Cenobamate | 858 | 894 | 81 | $1.4M |
| Lacosamide Generic | 760 | 882 | 85 | $162K |
| Levetiracetam Generic | 469 | 765 | 82 | $25K |
| Briviact Brivaracetam | 469 | 492 | 43 | $706K |
| Clobazam Generic | 437 | 480 | 55 | $85K |
| Lamotrigine Generic | 396 | 543 | 48 | $6,897 |
| Fycompa Perampanel | 374 | 375 | 40 | $474K |
| Zonisamide Generic | 292 | 418 | 43 | $15K |
| Vimpat Lacosamide | 270 | 284 | 27 | $424K |
| Lamotrigine Er Lamotrigine | 234 | 267 | 28 | $99K |
| Levetiracetam Er Levetiracetam | 231 | 342 | 32 | $39K |
| Nayzilam Midazolam | 181 | 182 | 82 | $170K |
| Onfi Clobazam | 131 | 147 | 13 | $522K |
| Lorazepam Generic | 128 | 134 | 56 | $631 |
| Clonazepam Generic | 127 | 127 | 12 | $868 |
Brand drugs: 3,170 claims; generic drugs: 3,970 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica Bishop $12K ($12K in general payments such as food, travel and fees) from 11 companies. The largest payer was UCB, Inc. with $7,964.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 20 | $7,964 |
| Neurelis, Inc. | 9 | $2,645 |
| Abbvie Inc. ABBV | 8 | $233 |
| SK Life Science, Inc. | 8 | $213 |
| Catalyst Pharmaceuticals, Inc. CPRX | 8 | $201 |
| Pfizer Inc. PFE | 10 | $143 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $141 |
| LivaNova USA, Inc. LIVN | 3 | $60.46 |
| Biocodex, Inc. | 1 | $26.8 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $22.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.